UNSPSC 51191533: Benzthiazide

This classification denotes a thiazide diuretic with the molecular formula C15H14ClN3O4S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1TD8J48L61, chemically known as 6-chloro-7-sulfamoyl-3-benzylthiomethyl-2h-1,2,4-benzothiadiazine 1,1-dioxide but generally known as benzthiazide, which bears US NIH Compound Identifier 2343. European Medicines Agency schedules Benzthiazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05769MIG.

UNSPSC 51191533 Benzthiazide is a Commodity code that captures pharmaceutical and chemical supply procurement by state and local governments, though the recent opportunities posted against this code diverge significantly from the code's nominal scope. The City of Meriden, Connecticut, solicited sodium bisulfite—a water-treatment chemical used at municipal pollution-control facilities—under this code in July 2026, indicating that state and local procurement offices are tagging chemical commodities across a broad range of industrial and municipal applications rather than limiting the code to pharmaceutical products. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted an RFP in January 2026 to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products distributed to participating state and local government facilities across Minnesota, Oregon, and other member jurisdictions. The issuing bodies span municipal water utilities, state health agencies, and cooperative purchasing consortia, with MMCAP representing a significant multi-state aggregation model that pools demand across participating jurisdictions.

The code shows active procurement in Connecticut and across the MMCAP member-state network (Minnesota and Oregon explicitly named), with the two recent opportunities spanning divergent product categories—industrial chemicals for municipal infrastructure and generic pharmaceuticals for health-care delivery. The City of Meriden's sodium bisulfite bid (B02715) closed July 29, 2026, and required General Liability coverage of $1,000,000 to $2,000,000, performance and labor-and-material payment bonds, and firm pricing for the contract term. MMCAP's RFP (S1070000015802) for generic pharmaceuticals and OTC products, due March 26, 2026, required vendors to supply through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health 110 and 112, and Morris & Dickson), maintain commercial general liability of $5 million per occurrence, certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, and accept a 3 percent administrative fee on all contract purchases. The RFP weighted price competitiveness at 75 percent of the evaluation score and reserved MMCAP's right to make sole, dual, or multi-awards based on therapeutic considerations and member-specific needs, with contract terms of two years for new vendors and optional extensions through June 30, 2028.